Bracco Imaging is partnering with Subtle Medical to advance the use of contrast-enhanced MRI on a worldwide basis.
Diagnostic imaging company Bracco Imaging is partnering with AI image acquisition developer Subtle Medical to integrate their technologies in an effort to advance the use of contrast-enhanced MRI around the world.
The global agreement will begin mainly in the U.S., where Bracco Imaging distributes its portfolio of products and services through its subsidiary, Bracco Diagnostics.
The companies said that investigating AI's potential in contrast-enhanced MRI could lead to more accurate and efficient image interpretation, improved diagnostic capabilities, and best practices for patient care.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
